Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients

Coeliac plexus block: utility of the anterior approach and the real time colour ultrasound guidance in cancer patient.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2001

Superior vena cava obstruction: is stenting necessary?

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2001

Percutaneous cementoplasty for pelvic bone metastasis.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2000

CD3 antibody-induced IL-10 in renal allograft recipients: an in vivo and in vitro analysis.

Transplantation·1999

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.

Kidney international·1998

Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·1996

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials.

Lancet (London, England)·2026

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

Lancet (London, England)·2026

Endometrial ablation plus levonorgestrel-releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding in The Netherlands (MIRA2): a multicentre, open-label, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.

Lancet (London, England)·2026

Distribution of Donor Types and Time to Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Across Ethnic Groups: A Retrospective Study.

Clinical transplantation·2026

Clot Out, Flow Back: Large-Bore Aspiration Thrombectomy for Symptomatic Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) Occlusion.

Cureus·2026

Not All Brain Bleeds Are Equal: An Etiology-First Framework for Stroke Prevention After Intracerebral Hemorrhage.

Cureus·2026

Factor H polymorphism elevates granzyme B and impairs complement inhibition in human and mouse models.

iScience·2026

Breaking the Storm: Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome as the First Manifestation of Systemic Lupus Erythematosus/Mixed Connective Tissue Disease in an Adolescent Successfully Treated With Anakinra.

Cureus·2026

Concizumab for the management of heavy menstrual bleeding in a woman with mild hemophilia A.

Research and practice in thrombosis and haemostasis·2026

Related Experiment Videos

Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients

Related Concept Videos

Coeliac plexus block: utility of the anterior approach and the real time colour ultrasound guidance in cancer patient.

Superior vena cava obstruction: is stenting necessary?

Percutaneous cementoplasty for pelvic bone metastasis.

CD3 antibody-induced IL-10 in renal allograft recipients: an in vivo and in vitro analysis.

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.

Adequacy of haemodialysis and nutrition in maintenance haemodialysis patients: clinical evaluation of a new on-line urea monitor.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials.

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

Endometrial ablation plus levonorgestrel-releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding in The Netherlands (MIRA2): a multicentre, open-label, randomised, controlled, superiority trial.

Disease-free survival and overall survival after neoadjuvant immunotherapy in mismatch repair-deficient colon cancer in the Netherlands: results of the single-arm, multicentre, phase 2, NICHE-2 trial.

Distribution of Donor Types and Time to Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Across Ethnic Groups: A Retrospective Study.

Clot Out, Flow Back: Large-Bore Aspiration Thrombectomy for Symptomatic Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) Occlusion.

Not All Brain Bleeds Are Equal: An Etiology-First Framework for Stroke Prevention After Intracerebral Hemorrhage.

Factor H polymorphism elevates granzyme B and impairs complement inhibition in human and mouse models.

Breaking the Storm: Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome as the First Manifestation of Systemic Lupus Erythematosus/Mixed Connective Tissue Disease in an Adolescent Successfully Treated With Anakinra.

Concizumab for the management of heavy menstrual bleeding in a woman with mild hemophilia A.

Related Experiment Videos

Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients

Related Concept Videos

Related Articles